title: [Spondylarthropathy with Behçet's disease: response to infliximab].
authors.affiliation: Service de Rhumatologie, CHU Hôpital Minjoz, EA 3186 Agents Pathogènes et Inflammation, Université de Franche-Comté, F-25000 Besançon, France. etoussirot@chu-besancon.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Toussirot
authors.forename: Claire
authors.initials: C
authors.lastname: Schwartz
authors.forename: Chafika
authors.initials: C
authors.lastname: Hafsaoui
authors.forename: Marie
authors.initials: M
authors.lastname: Bossert
authors.forename: Ewa
authors.initials: E
authors.lastname: Bertolini
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D025242:Spondylarthropathies / Q000150:complications* / Q000000981:diagnostic imaging / Q000378:metabolism; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab